# Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol

> **NCT03285295** · NA · COMPLETED · sponsor: **Abbott Diagnostics Division** · enrollment: 106881 (actual)

## Conditions studied

- Healthy

## Interventions

- **DEVICE:** Alinity s HBsAg and Alinity s HBsAg Confirmatory Assay
- **DEVICE:** Alinity s HTLV I/II Assay
- **DEVICE:** Alinity s Anti-HCV Assay
- **DEVICE:** Alinity s HIV Ag/Ab Combo Assay
- **DEVICE:** Alinity s Anti-HBc Assay
- **DEVICE:** Alinity s Chagas Assay

## Key facts

- **NCT ID:** NCT03285295
- **Lead sponsor:** Abbott Diagnostics Division
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-15
- **Primary completion:** 2018-05-23
- **Final completion:** 2018-06-21
- **Target enrollment:** 106881 (ACTUAL)
- **Last updated:** 2019-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03285295

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03285295, "Abbott Laboratories Alinity s Blood Screening Assays - Clinical Evaluation Protocol". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03285295. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*